BlueCrest Capital Management Ltd Acquires Shares of 250,000 Healthcare Capital Acquisition Corp. $HCAC

BlueCrest Capital Management Ltd acquired a new stake in shares of Healthcare Capital Acquisition Corp. (NASDAQ:HCAC) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 250,000 shares of the company’s stock, valued at approximately $2,510,000. BlueCrest Capital Management Ltd owned approximately 0.67% of Healthcare Capital Acquisition as of its most recent SEC filing.

Separately, Governors Lane LP bought a new position in shares of Healthcare Capital Acquisition in the 2nd quarter worth $2,761,000. 66.82% of the stock is currently owned by hedge funds and other institutional investors.

Healthcare Capital Acquisition Stock Down 0.1%

HCAC stock opened at $10.10 on Thursday. The firm has a market capitalization of $376.80 million, a PE ratio of 202.00 and a beta of 0.41. Healthcare Capital Acquisition Corp. has a twelve month low of $9.91 and a twelve month high of $10.11. The stock’s 50 day moving average is $10.07 and its 200-day moving average is $10.02.

Analysts Set New Price Targets

Separately, Weiss Ratings began coverage on shares of Healthcare Capital Acquisition in a research note on Monday, August 24th. They set a “sell (e+)” rating for the company. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Healthcare Capital Acquisition has a consensus rating of “Sell”.

Healthcare Capital Acquisition (NASDAQ: HCAC) is a special purpose acquisition company (SPAC), commonly referred to as a blank‑check company, formed to raise capital through a public listing and pursue one or more business combinations. As a SPAC, Healthcare Capital Acquisition does not operate commercial businesses of its own; instead it holds funds in trust while identifying and negotiating a merger, acquisition or other business combination with an operating company, with a stated focus on opportunities in the healthcare sector.

The firm’s primary activities include sourcing and evaluating potential targets in healthcare and life sciences, structuring transactions, and completing a business combination that would result in the target becoming a publicly listed company.